Skip to main content

Everolimus

NDC 0093-7766 · Teva Pharmaceuticals USA, Inc.

FDA lists marketing as ended on 2026-09-30.
Generic nameEverolimus
Dosage formTABLET
RouteORAL
Active ingredient(s)EVEROLIMUS
Strength2.5 mg/1
Pharmacologic classCytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
Marketing categoryANDA

Packages

0093-7766-24 — 28 BLISTER PACK in 1 CARTON (0093-7766-24) / 1 TABLET in 1 BLISTER PACK (0093-7766-19)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0078-0415 — everolimus, 0078-0417 — everolimus, 0078-0422 — everolimus, 0078-0566 — everolimus, 0078-0567 — everolimus, 0078-0594 — everolimus, 0078-0620 — everolimus, 0078-0626 — everolimus, 0078-0627 — everolimus, 0078-0628 — everolimus, 0093-7767 — Everolimus, 0093-7768 — Everolimus, 0093-7769 — Everolimus, 0245-0822 — Everolimus, 0245-0823 — Everolimus, 0245-0824 — Everolimus, 0245-0825 — Everolimus, 49884-158 — Everolimus, 49884-159 — Everolimus, 49884-160 — Everolimus, +63 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources